AP
SIBN icon

Antipodes Partners’s SI-BONE Inc SIBN Stock Holding History

Antipodes Partners’s Portfolio SIBN Stock Details SIBN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81K Sell
4,965
-599
-11% -$8.56K ﹤0.01% 108
2026
Q1 		$70.3K Buy
5,564
+4,094
+279% +$64.1K ﹤0.01% 102
2025
Q4 		$29K Buy
+1,470
New +$25.5K ﹤0.01% 118
2025
Q2 		– Sell
-2,394
Closed -$33.6K – 123
2025
Q1 		$33.6K Buy
+2,394
New +$38.6K ﹤0.01% 90

Other funds holding SIBN

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Antipodes Partners's SIBN Position: Q2 2026 in Review

Antipodes Partners reduced its SI-BONE Inc (SIBN) stake by 11% in Q2 2026, selling an estimated $8.56K and leaving 4,965 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #108.

Antipodes Partners first reported a position in SIBN in Q1 2025 and has held it in 4 quarters since. 168 funds tracked by Wall St. Rank hold SIBN as of Q2 2026.

  • Antipodes Partners held 4,965 shares of SI-BONE Inc worth $81K as of Q2 2026.
  • Antipodes Partners sold 599 SI-BONE Inc shares in Q2 2026, an estimated $8.56K.
  • SI-BONE Inc made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #108 holding.
  • Antipodes Partners first reported a position in SI-BONE Inc in Q1 2025 and has held it in 4 quarters since.
  • 168 funds tracked by Wall St. Rank held SI-BONE Inc as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.